Evidence map›Paper›PMID 38856931›Full record

ArticleCellular and molecular life sciences : CMLS2024

Pyruvate kinase M2 sustains cardiac mitochondrial quality surveillance in septic cardiomyopathy by regulating prohibitin 2 abundance via S91 phosphorylation.

Yingzhen Du, Jialei Li, Zhe Dai, Yuxin Chen, Yao Zhao, Xiaoman Liu, Tian Xia, Pingjun Zhu, Yijin Wang

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. PKM2: A gatekeeper in macrophage metabolic reprogramming.Journal of pharmaceutical analysis · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yingzhen DuThe Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
Jialei LiSchool of Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Zhe DaiSchool of Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Yuxin ChenSchool of Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Yao ZhaoSchool of Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Xiaoman LiuSchool of Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Tian XiaDepartment of Clinical Laboratory Medicine, The First Medical Centre, Medical School of Chinese People's Liberation Army, Beijing, China.
Pingjun ZhuThe Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China. zhupingjun@outlook.com.
Yijin WangThe Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China. yijinwang03@hotmail.com.ORCID http://orcid.org/0009-0009-5507-3673

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endogenous mitochondrial quality control (MQC) system serves to protect mitochondria against cellular stressors. Although mitochondrial dysfunction contributes to cardiac damage during many pathological conditions, the regulatory signals influencing MQC disruption during septic cardiomyopathy (SC) remain unclear. This study aimed to investigate the involvement of pyruvate kinase M2 (PKM2) and prohibitin 2 (PHB2) interaction followed by MQC impairment in the pathogenesis of SC. We utilized LPS-induced SC models in PKM2 transgenic (PKM2

Indexed as

CardiomyopathiesMitochondria, HeartProhibitinsPyruvate KinaseRepressor ProteinsSepsisAnimalsHumansLipopolysaccharidesMaleMiceMice, Inbred C57BLMice, TransgenicMitophagyMyocytes, CardiacPhosphorylationLipopolysaccharidesPhb2 protein, mousePkm protein, mouseProhibitinsPyruvate KinaseRepressor ProteinsMitochondriaMQCPHB2PKM2Septic cardiomyopathy

Identifiers

PMID38856931
PMCPMC11335292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.